Related Experiment Video
Updated: Aug 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
[Regulation of growth inhibition by transforming growth factor beta1 in rhabdomyosarcoma RD cell line]
Lü Ye1, Hong-Ying Zhang, Hong Bu
1Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.
Objective:
To study the regulatory effect of TGF-beta1 on growth of rhabdomyosarcoma RD cell line.
Methods:
After various durations of TGF-beta1 treatment, the viability of RD cell line was examined by growth rate measurement, MTT assay and (3)H-thymidine incorporation. The cell cycle was analyzed by flow cytometry. Immunofluorescent staining was used to localize p15, p21 and p27 in RD cell line under laser scanning confocal microscope. The protein and mRNA of p15, p21 and p27 in RD cell line were detected by western blot and reverse transcriptase-polymerase chain reaction respectively.
Results:
The viability of RD cell line treated with TGF-beta1 was obviously decreased. RD cell line was arrested in G(1) phase by TGF-beta1. There was increased expression of p21 and p27 in RD cell line with TGF-beta1 treatment at protein and mRNA levels. The expression of p21 in RD cell line was seen in both nucleus and cytoplasm after 24 hours of TGF-beta1 treatment. The expression of p15 showed no obvious changes upon TGF-beta1 treatment.
Conclusions:
TGF-beta1 inhibits growth of RD cell line and induces G(1)-arrest. It up-regulates protein and mRNA of p21 and p27 and shows no obvious influence on p15 expression. The growth arrest of RD cell line may result from the up-regulation of p21 and p27 by TGF-beta1.
Insights
Transforming growth factor-beta1 (TGF-beta1) inhibits rhabdomyosarcoma RD cell growth and induces G(1)-arrest. This effect is mediated by up-regulating p21 and p27 expression, impacting cell cycle progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Context:
- Rhabdomyosarcoma is a pediatric soft tissue sarcoma.
- Understanding the molecular mechanisms regulating rhabdomyosarcoma cell growth is crucial for developing targeted therapies.
Purpose:
- To investigate the regulatory effect of transforming growth factor-beta1 (TGF-beta1) on the proliferation of the rhabdomyosarcoma RD cell line.
- To elucidate the role of cell cycle regulatory proteins p15, p21, and p27 in mediating TGF-beta1's effect.
Summary:
- TGF-beta1 treatment significantly decreased the viability of RD cells.
- Flow cytometry revealed that TGF-beta1 induced cell cycle arrest at the G(1) phase.
- Western blot and RT-PCR demonstrated increased protein and mRNA levels of p21 and p27, while p15 expression remained unchanged.
Impact:
- TGF-beta1 acts as a potent inhibitor of rhabdomyosarcoma RD cell growth.
- The findings suggest that TGF-beta1-induced G(1)-arrest is mediated by the upregulation of p21 and p27.
- This study provides insights into potential therapeutic strategies targeting TGF-beta1 signaling in rhabdomyosarcoma.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Abnormal Proliferation
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
